Technical Analysis for ALBT - Avalon GloboCare Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 2.58% | |
| Wide Bands | Range Expansion | 2.58% | |
| Gapped Down | Weakness | 2.58% | |
| 20 DMA Resistance | Bearish | -11.75% | |
| Narrow Range Bar | Range Contraction | -11.75% | |
| Wide Bands | Range Expansion | -11.75% |
| Alert | Time |
|---|---|
| Up 1% | about 18 hours ago |
| Possible NR7 | about 18 hours ago |
| Possible Inside Day | about 18 hours ago |
| 60 Minute Opening Range Breakout | about 18 hours ago |
| Down 3% | about 22 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/11/2024
Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
Sector: Healthcare
Industry: Medical Care
Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Bioproduction Vesicles
Classification
Sector: Healthcare
Industry: Medical Care
Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Bioproduction Vesicles
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.6 |
| 52 Week Low | 2.12 |
| Average Volume | 814,417 |
| 200-Day Moving Average | 4.93 |
| 50-Day Moving Average | 3.16 |
| 20-Day Moving Average | 3.16 |
| 10-Day Moving Average | 3.09 |
| Average True Range | 0.54 |
| RSI (14) | 43.18 |
| ADX | 22.85 |
| +DI | 29.41 |
| -DI | 24.15 |
| Chandelier Exit (Long, 3 ATRs) | 3.06 |
| Chandelier Exit (Short, 3 ATRs) | 3.75 |
| Upper Bollinger Bands | 3.96 |
| Lower Bollinger Band | 2.36 |
| Percent B (%b) | 0.26 |
| BandWidth | 50.79 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.08 |
| MACD Histogram | -0.0363 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.05 | ||||
| Resistance 3 (R3) | 3.05 | 2.96 | 3.00 | ||
| Resistance 2 (R2) | 2.96 | 2.89 | 2.96 | 2.99 | |
| Resistance 1 (R1) | 2.87 | 2.85 | 2.91 | 2.87 | 2.97 |
| Pivot Point | 2.78 | 2.78 | 2.80 | 2.78 | 2.78 |
| Support 1 (S1) | 2.69 | 2.71 | 2.74 | 2.69 | 2.59 |
| Support 2 (S2) | 2.60 | 2.67 | 2.60 | 2.57 | |
| Support 3 (S3) | 2.51 | 2.60 | 2.56 | ||
| Support 4 (S4) | 2.51 |
